by IgG | Apr 9, 2014 | News
In an effort to reduce the mortality and morbidity by snakebite envenomation, the health authorities of Mali have started using our antivenom. The production of antivenom is complex and due to increasing demand, measures have been taken to increase the number of vials...
by IgG | Feb 27, 2014 | News
Where and how is the antivenom EchiTAb-Plus-ICP produced in Costa...
by IgG | Nov 27, 2013 | News
The supply to MSF is for their humanitarian work in this country.
by IgG | Aug 27, 2013 | News
EchiTAb-Plus-ICP has been well received in Burkina Faso, where it has been used effectively against the most common venomous snakes, such as the West African Carpet Viper, the Puff Adder and the Blacked-Necked Spitting Cobra.
by IgG | Oct 16, 2012 | News
The highest incidence of snakebite in Africa occurs in the West African savanna region. In this region, saw-scaled or carpet vipers (E. ocellatus, E. leucogaster, E. jogeri), spitting cobras (Naja nigricollis and N. katiensis) and puff adders (Bitis arietans) are...
by IgG | Oct 16, 2012 | News
Envenoming by snakes is an important public health problem in Africa, where an estimated 500000 cases occur annually (Chippaux, 1998a), resulting in high mortality and morbidity (Chippaux, 1998a; Theakston et al., 2003; Warrell and Arnett, 1976). Currently,...
